Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca presents novel Src kinase inhibitors

June 7, 2002

Finalization of phase III protocol for Xyotax in NSCLC and ovarian cancer

June 6, 2002

J591 has antitumor effects in patients with advanced prostate cancer

June 5, 2002

New data on DC101 presented at the AUA meeting

June 5, 2002

All patients with aggressive NHL respond to Onco TCS combination therapy

June 5, 2002

Iseganan hydrochloride prevents oral mucositis in phase III trial

June 5, 2002

Antitumor platinum complexes designed at AnorMED

June 5, 2002

Corixa files request for formal dispute resolution for Bexxar

June 4, 2002

Advectus collaborates with U. of N. Carolina on brain tumor drug development

June 4, 2002

Phase I study of aplidine as a three-hour infusion in solid tumor patients

June 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...